Wednesday, June 14

Start End Title
Patient Meeting Session I
13:45 14:15 Holger Prokisch: State of the art in the diagnosis of mitochondrial disorders
14:15 15:00 Thomas Klopstock: New therapies, current trials, future developments
15:00 15:30 Grainne Gorman: Rehabilitation in mitochondrial diseases
15:15 16:30 Ask the Mito Doc (Thomas Klopstock, Jan Smeitink, Laurence Bindoff, Bobby McFarland, Shamima Rahman, Mirian Janssen, Holger Prokisch)
16:30 17:00 Coffee Break
17:00 18:00 Living with a mitochondrial disease
(combined session for EUROMIT2017 and Patient meeting)
17:00 17:30 Shanalle Hamilton 
17:30 18:00 Rachael Wells 


Thursday, June 15

Start End Title
Session VIII - Therapeutic strategies for mitochondrial diseases-part 2
(combined session for EUROMIT2017 and Patient meeting)
09:00 09:30 Michio Hirano: Development of a Pharmacological Therapy for Thymidine Kinase 2 Deficiency
09:30 10:00 Mary Herbert: IVF-based technologies to prevent germline transmission of mtDNA disease
10:00 10:30 Jan Smeitink: Mitochondrial disease small molecule drug development
10:30 11:00 Coffee Break
12:00 13:00 Lunch
Patient Meeting - Session  II 
13:00 13.30 Michelangelo Mancuso: Registries and natural history studies 
13:30 14:30 Doug Turnbull: Mitochondrial replacement: state of the art
14:30 15:30 Piero Santantonio and Phil Yeske: The IMP Patient Register and the role of Patient Advocacy Groups
15:30 16:00 Coffee Break
16:00 17:00 S. Becker, M. Löffler: The IMP Quality Of Life study pilot in Germany
17:00 17:30 Chris Verhaak: Psychological impact of the m. 3243A>G mutation
17:30 18:00 Jan Smeitink: Final remarks

If you have any questions please contact us at